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Matriptase, a membrane-tethered serine protease, plays essential roles in epidermal differentiation and barrier function,
largely mediated via its activation of prostasin, a glycosylphosphatidylinositol-anchored serine protease. Matriptase activity is
tightly regulated by its inhibitor hepatocyte growth factor activator
inhibitor-1 (HAI-1) such that free active matriptase is only briefly
available to act on its substrates. In the current study we provide
evidence for how matriptase activates prostasin under this tight
control by HAI-1. When primary human keratinocytes are induced
to differentiate in a skin organotypic culture model, both
matriptase and prostasin are constitutively activated and then
inhibited by HAI-1. These processes also occur in HaCaT human
keratinocytes when matriptase activation is induced by exposure of
the cells to a pH 6.0 buffer. Using this acid-inducible activation
system we demonstrate that prostatin activation is suppressed by
matriptase knockdown and by blocking matriptase activation with
sodium chloride, suggesting that prostatin activation is dependent
on matriptase in this system. Kinetics studies further reveal that the
timing of autoactivation of matriptase, prostasin activation, and
inhibition of both enzymes by HAI-1 binding are closely correlated. These data suggest that, during epidermal differentiation,
the matriptase-prostasin proteolytic cascade is tightly regulated by
two mechanisms: 1) prostasin activation temporally coupled to
matriptase autoactivation and 2) HAI-1 rapidly inhibiting not only
active matriptase but also active prostasin, resulting in an
extremely brief window of opportunity for both active matriptase
and active prostasin to act on their substrates.

Matriptase, a type II transmembrane serine protease, plays
essential roles in epidermal differentiation and barrier function
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(1, 2). Mutations of matriptase are associated with autosomal
recessive ichthyosis and hypotrichosis (3). Four mutations have
been identified in ST14, the gene that encodes for matriptase
(3–5). Targeted deletion of matriptase in mice also causes
severe epidermal defects with impairment of desquamation,
lipid matrix formation, and profilaggrin processing. These defects lead to compromised epidermal barrier function and postnatal death (2). The severe epidermal defects appear to result
from the lack of activation of the glycosylphosphatidylinositolanchored serine protease prostasin by matriptase, because both
matriptase-deficient and prostasin-deficient mice share an
almost identical pattern of epidermal defects. Furthermore,
lack of prostasin activation was observed in matriptase-deficient mouse skin (6, 7), suggesting that much of the function of
matriptase in the epidermis is manifested through the activation of prostasin.
Hepatocyte growth factor activator inhibitor-1 (HAI-1)2 is a
transmembrane Kunitz-type serine protease inhibitor (8).
HAI-1 can inhibit matriptase in a competitive and reversible
manner, consistent with the characteristics of Kunitz-type serine protease inhibitors (9). What is unusual, however, is its high
efficiency of matriptase inhibition by HAI-1. As a consequence
of this efficiency, free active matriptase is rapidly inactivated by
HAI-1 binding and can only act on its downstream substrates
for extremely short time periods after activation (10 –12). This
unusually efficient inhibition results not only from the high
inhibitory potency of HAI-1 (13) and the subcellular co-localization of enzyme and inhibitor (11) but also from several
uncommon biochemical mechanisms. For example, most
matriptase-expressing epithelial cells express HAI-1 in significantly higher levels compared with the levels of matriptase, typically in excess of 10-fold molar excess.3 In the absence of
HAI-1, newly synthesized matriptase accumulates within the
endoplasmic reticulum/Golgi, which results in very low levels
of matriptase being expressed (11). HAI-1 may also participate
2

3

The abbreviations used are: HAI-1, hepatocyte growth factor activator inhibitor-1; ENaC, epithelial sodium channel.
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in matriptase zymogen activation, because matriptase activation is significantly reduced when point mutations are introduced into the LDL receptor class A domain of HAI-1, or this
domain is deleted (14). This unusual relationship between
matriptase and HAI-1 appears to result in two unique consequences: 1) the very short-lived availability of free active
matriptase, due to the direct and rapid access of HAI-1 to the
newly generated active matriptase, and 2) a paradoxical reduction, rather than increase in matriptase activity in the absence
of HAI-1. The short-lived availability of active matriptase suggests that activation of the downstream matriptase substrate
must be coupled with matriptase’s own activation. The paradoxical decrease in matriptase function associated with HAI-1
deficiency appears to be consistent with animal studies in
which the epidermal defects seen in HAI-1-deficient mice resemble those in matriptase hypomorphic mice (15, 16).
Although data from genetic manipulation models and studies of tissue distribution clearly demonstrate a close functional
linkage between matriptase and prostasin and their essential
roles in epidermal function, the details of how and when the
activation of prostasin by active matriptase occurs, remain
largely unknown. In the current study, we examine the expression and activation state of matriptase and prostasin during
epidermal differentiation using an organotypic skin culture
model and dissect the molecular events associated with the
activation and inactivation of these enzymes. Our results demonstrate that matriptase and prostasin are rapidly and constitutively activated throughout the course of epidermal differentiation, consistent with their roles in skin function. More
importantly, although HAI-1 rapidly inhibits active matriptase,
immediately after matriptase zymogen activation, the active
matriptase apparently has no difficulty activating prostasin in
the brief window of opportunity, prior to its inactivation by
HAI-1. Unexpectedly, active prostasin appears to follow the
same fate as active matriptase and is rapidly inactivated by
binding with HAI-1. These data suggest that epidermal keratinocytes regulate matriptase-initiated cell surface proteolysis
with unprecedentedly tight control to safeguard themselves
from the proteolytic activities of matriptase and prostasin.

EXPERIMENTAL PROCEDURES
Antibodies—Two types of matriptase antibodies were used:
the mouse monoclonal antibodies (mAbs) M32 and M24 and
rat mAb 21-9 recognize both latent and activated forms of
matriptase (17–19); mAb M69 recognizes an epitope present
only on activated matriptase and is, therefore, able to distinguish activated matriptase from latent matriptase (9, 20).
Human HAI-1 protein was detected using the HAI-1 mAb M19
(17). Two prostasin antibodies were used: a prostasin polyclonal antibody, described previously (21, 22), which is able to
recognize both activated prostasin in complex with HAI-1 and
uncomplexed prostasin, which is presumably the latent form of
the enzyme. Interestingly, this antibody appears to recognize
the prostasin-HAI-1 complex better than latent prostasin. The
second antibody was a prostasin mAb (BD Biosciences, Franklin Lakes, NJ) that only recognizes prostasin after heat-denaturing treatment, which results in the dissociation of the prostasinHAI-1 complex.
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Lentiviral Particle Preparation and Cell Transduction for the
Delivery of shRNAs—Matriptase-targeting and non-targeting
control small hairpin RNAs (shRNA) in the vector PLKO.1puro were purchased from Open Biosystems (Huntsville, AL).
The shRNA constructs were packaged into lentiviral particles
using 293T cells using standard methods. Briefly, on day 1,
293T cells were switched to fresh media without antibiotics 3 h
prior to transfection. Ten micrograms of the shRNA plasmids
were mixed with 5 g of vesicular stomatitis virus glycoprotein,
5 g of d89, 50 l of CaCl2, and water to a total volume of 500
l. The mixture was then mixed with 500 l of 2⫻ Hebs buffer
(dextrose 2.0 g/liter, HEPES, 10 g/liter, KCI 0.74 g/liter, NaCl
16 g/liter, Na2HPO4.2H2O 0.27 g/liter and incubated at room
temperature for 20 min. The resultant mixture was then added
dropwise onto a 100-mm dish of 293T cells, and the cells were
incubated overnight at 37 °C, with 5% CO2. The following day,
the transfection media were replaced with fresh media, and the
cultures were again incubated overnight. On the third day, conditioned media were harvested from the plates and filtered
through a 22-m polyethersulfone syringe-driven filter unit.
Cell Culture and Media—The immortalized human keratinocyte line HaCaT was cultured in DMEM (Cellgro, Manassas,
VA) supplemented with 10% FBS (Gemini, West Sacramento,
CA), 100 units/ml penicillin, and 100 g/ml streptomycin. Primary human keratinocytes isolated from neonatal foreskin tissue were cultured in keratinocyte serum-free media (Invitrogen) supplemented with 25 g/ml bovine pituitary extract and
1.5 ng/ml of recombinant epidermal growth factor. Cultures
were maintained in a humidified 5% CO2 atmosphere at 37 °C.
Organotypic Culture—Organotypic raft cultures were generated based on the method described previously (23, 24). Collagen (type I rat tail, BD Biosciences, Bedford, MA) plugs with 105
J2–3T3 fibroblasts per milliliter were prepared in 6-well cell
culture inserts (0.4-m pore size, PET track-etched membrane,
BD Biosciences), and incubated for 1 day. A total of 106 primary
human keratinocytes was plated on top of each plug in keratinocyte serum-free media supplemented with 25 g/ml bovine
pituitary extract and 1.5 ng/ml recombinant epidermal growth
factor. After 2 days, primary human keratinocyte differentiation was initiated by lifting the organotypic cultures to the airliquid interface and changing the culture medium to keratinocyte serum-free media supplemented with 25 g/ml bovine
pituitary extract, 1.5 ng/ml recombinant epidermal growth factor. The medium was changed every second day for the next 8
days.
Acid-induced Matriptase Activation in HaCaT Cells—
Matriptase activation was induced by exposing HaCaT cells to a
0.15 M phosphate buffer (PB), pH 6.0, for 30 min at room temperature, as described previously (18). For the activation kinetics assay, the cells were incubated with PB for various times as
indicated in the figure. Cell lysates were harvested and subjected to immunoblot analysis.
Immunoblot Analysis—Proteins for immunoblot analysis
were prepared from the organotypic cultures and regular cell
cultures by washing the cells three times with phosphate-buffered saline (PBS, Cellgro), followed by dissolving cells in 1%
Triton X-100 in PBS at 4°C for 5 min. Insoluble debris was
removed by centrifugation. The protein concentrations in these
VOLUME 285 • NUMBER 41 • OCTOBER 8, 2010
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lysates were determined using the BCA protein assay reagents
(Pierce) according to the manufacturer’s instructions. Samples
containing the same amount of total protein were mixed with
5⫻ sample buffer and resolved by 7.5% SDS-PAGE and then
transferred to nitrocellulose membrane (Pall Corp., Pensacola,
FL). The membranes were probed with the appropriate antibodies and an HRP-conjugated secondary antibody (Kirkegaard & Perry Laboratories, Gaithersburg, MD), before signal
detection with Western Lightning Chemiluminescence Reagent Plus (PerkinElmer Life Sciences).
Prostasin-HAI-1 Complex Purification—HaCaT cells were
treated with PB for 30 min at room temperature to activate
prostasin and induce prostasin-HAI-1 complex formation.
After activation, the cells were washed three times with PBS
and lysed with 1% Triton X-100 in PBS. The cell lysates were
centrifuged to remove insoluble debris and then dialyzed
against 20 mM Tris-HCl, pH 8.0, containing 1% Triton X-100
(buffer A). The dialyzed sample was loaded onto a DEAESepharose Fast Flow column (Amersham Biosciences) preequilibrated with buffer A. The DEAE column was washed with
5 column volumes of buffer A, and proteins were eluted with a
linear gradient of 0 to 0.5 M NaCl in buffer A. The eluted fractions containing the prostasin-HAI-1 complex were pooled and
loaded onto a HAI-1 mAb M19 immunoaffinity column preequilibrated with buffer A. The column was washed with buffer
A, and bound protein was then eluted with 0.1 N glycine-HCl,
pH 2.4. The eluate fractions were neutralized immediately after
collection with 2 M Trizma Base.
Mass Spectrometry Analysis and Identification of Prostasin—
The protein bands from SDS-PAGE gels stained with Protoblue
(National Diagnostics, Atlanta, GE) were excised, washed,
destained, and trypsinized overnight at 37 °C using standard
protocols after dithiothreitol reduction and iodoacetamide
alkylation. Analysis of the tryptic peptides derived from the
protein samples was performed by liquid chromatography/
mass spectrometry (LS/MS) using services provided by Prottech Inc. (Norristown, PA).

RESULTS
Activation of Matriptase Starts Early, and Is Maintained
throughout, in Vitro Human Epidermal Differentiation—Epidermal differentiation involves a host of proteases and protease
inhibitors of which matriptase is an essential player in the
development of skin barrier function. Here we used a threedimensional organotypic skin cultures to examine the functional status of matriptase during epidermal differentiation.
When cultured as a monolayer, primary human keratinocytes
express matriptase in its mature latent form, yielding a 70-kDa
protein band on immunoblots using matriptase mAb M24
(Fig. 1, Total MTP, lanes M). The cells are devoid of activated
matriptase as shown by the lack of a band recognized by the
mAb M69, which can specifically distinguish active matriptase
from latent matriptase (Fig. 1, Activated MTP, lanes M). The
cognate inhibitor of matriptase, HAI-1, is also expressed by
human keratinocytes in monolayer culture, detectable in its uncomplexed form at 55-kDa detected by HAI-1 mAb M19 (Fig. 1,
HAI-1, lanes M).
OCTOBER 8, 2010 • VOLUME 285 • NUMBER 41

FIGURE 1. Detection of a novel HAI-1 complex in differentiating human
keratinocytes. Primary human keratinocytes were grown in monolayer (M)
or in a skin organotypic culture system (R). Cells were harvested on the second
or eighth days after they were lifted to the air-liquid interface and analyzed by
immunoblot for total matriptase (Total MTP), activated matriptase (activated
MTP), and HAI-1.

To study how matriptase is regulated during epidermal differentiation, epidermal organotypic cultures were established
using primary human keratinocytes grown on collagen lattices
prepared with fibroblasts. Two days after being lifted to the
air-liquid interface, significant activation of matriptase occurs,
as indicated by the appearance of a 120-kDa (activated)
matriptase-HAI-1 complex, which can be detected by all three
mAbs: M24, M69, and M19 (Fig. 1, 2 days, lanes R). These data
suggest that matriptase activation occurs at an early stage of
epidermal differentiation. Keratinocytes appear to employ
HAI-1 to inhibit matriptase in a fashion identical to that of
other types of epithelial cell, with the active matriptase being
rapidly inactivated by the formation of a 120-kDa matriptaseHAI-1 complex. In addition to this species, however, we
noticed that differentiating keratinocytes also form an 85-kDa
HAI-1 complex (Fig. 1, 2 days, HAI-1, lane R). The level of the
85-kDa HAI-1 complex detectable in the lysates appeared to be
comparable to that of the 120-kDa matriptase-HAI-1 complex
in epidermal keratinocytes, and yet an 85-kDa HAI-1 complex
has not been noticed or reported in other epithelial systems,
such as 184 A1N4 mammary epithelial cells suggesting that this
species is not present in other epithelial systems (18). Because
HAI-1 only binds and forms stable complexes with active but
not latent serine proteases, the appearance of the 85-kDa HAI-1
complex suggests that a second serine protease may be being
activated and then bound by HAI-1 in differentiating keratinocytes. The matriptase-HAI-1 complex and 85-kDa HAI-1 complex were also detected in raft culture lysates prepared on the
8th day of culture (Fig. 1, 8 Days), suggesting that the activation
of matriptase and the putative second serine protease may be
maintained during the course of epidermal differentiation.
Acid Exposure Induces Simultaneous Activation of Matriptase
and a Putative Serine Protease in HaCaT Cells—The appearance
of the 85-kDa HAI-1 complex throughout the course of keratinocyte differentiation in the organotypic skin culture model
might be related to activation of matriptase in a keratinocyteselective manner. Previously we discovered using other epithelial cells that robust matriptase activation can rapidly be
induced by simply exposing the cells to mildly acidic conditions
JOURNAL OF BIOLOGICAL CHEMISTRY
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mildly acidic pH, and this may contribute to matriptase autoactivation (25). Furthermore, matriptase zymogen activity can
also be inhibited by elevated concentrations of sodium chloride
and so can the autoactivation of matriptase in 184 A1N4
mammary epithelial cells (12, 25). The HaCaT cells also appear
to exhibit the NaCl-mediated inhibition of acid-induced
matriptase activation, because the levels of the 120-kDa
matriptase-HAI-1 complex were significantly reduced in the
presence of increased NaCl (Fig. 2, compare lanes 2 to lanes 3).
Interestingly, sodium chloride also significantly suppressed formation of the 85-kDa HAI-1 complex (Fig. 2, HAI-1, compare lane
2 to lane 3). These data suggest that formation of the 85-kDa
HAI-1 complex may be an event common to keratinocytes and
that its appearance is associated with matriptase activation.
Purification of the 85-kDa HAI-1 Complex and Identification
of Prostasin as a Component of the Complex—To identify the
putative serine protease that binds to HAI-1 to form the 85-kDa
complex, the complex was isolated from cell lysates prepared
from acid-exposed HaCaT cells using a combination of DEAE
chromatography, immunodepletion to remove the 120-kDa
matriptase-HAI-1 complex using immobilized matriptase mAb
21-9, and immunoaffinity chromatography using immobilized
HAI-1 mAb M19. Following these procedures, the 85-kDa
HAI-1 complex was visualized by Protoblue protein staining of
an SDS gel under non-boiled and non-reducing conditions (Fig.
3A, lane 1, a). Heat-denaturing the sample resulted in dissociation of the 85-kDa HAI-1 complex, and was accompanied by
the appearance of bands at 55 and 35 kDa (Fig. 3A, lane 2, b and
c, respectively). The heat-sensitive nature of the 85-kDa complex is consistent with the non-covalent interactions between
serine proteases and Kunitz-type serine protease inhibitors. InFIGURE 2. Acid-induced activation of matriptase is associated with the gel trypsin digestion and MS-based protein identification
formation of a novel 85-kDa HAI-1 complex in immortalized human revealed that the 85-kDa protein band contained HAI-1, as
keratinocytes. HaCaT cells were incubated with basal media (Basal, lane 1) or
phosphate buffer (PB), pH 6.0, with 0.15 M NaCl (PB⫹NaCl, lane 2) or PB, pH 6.0, expected, and the serine protease prostasin (Fig. 3B). The conalone (PB, lane 3) for 30 min. Cell lysates were extracted and subjected to stituents of 85-kDa prostasin-HAI-1 complex were further
immunoblot analyses for total matriptase (Total MTP), activated matriptase
confirmed by MS-based protein identification of the bands
(Activated MTP), and HAI-1.
yielded by heat denaturation of the
85-kDa complex with the 35-kDa
band being confirmed as prostasin
and the 55-kDa band as HAI-1 (Fig.
3B). Immunoblot analysis using a
prostasin antibody also confirmed
that the 85-kDa HAI-1 complex
contained prostasin under nonboiled and non-reducing conditions (Fig. 3C, lane 1), and that the
35-kDa protein band released
from heat-denaturing was indeed
prostasin (Fig. 3C, lane 2). These
data and those described above
suggest that keratinocytes simulFIGURE 3. Identification of prostatin as a component of the novel 85-kDa HAI-1 complex. A, partially taneously activate matriptase and
purified 85-kDa HAI-1 complex was analyzed by SDS-PAGE under either non-reducing and non-boiled condi- prostasin throughout the course of
tions (NRNB) or under non-reducing and boiled conditions (NR, B), and the protein bands were visualized by
epidermal differentiation, and in
staining with Protoblue. B, the protein bands indicated by a, b, and c in A were subjected to proteomic protein
identification by MS/MS. Among the tryptic peptides obtained from protein band a, 12 peptides matched to response to acid exposure, and
HAI-1 and 6 peptides matched to prostasin. Thirteen peptides obtained from band b matched to HAI-1, and that both active matriptase and
three from band c matched to prostasin. C, the purified 85-kDa HAI-1 complex was analyzed by immunoblot for
prostasin under either non-reducing and non-boiled conditions (NRNB) or non-reducing and boiled conditions active prostasin are rapidly inhib(NR, B) using a prostasin polyclonal antibody.
ited by HAI-1.

(12, 18). We, therefore, tested if this would occur in keratinocytes by exposing HaCaT cells to a pH 6.0 buffer and found that
acid exposure of these cells resulted in the rapid conversion of
the 70-kDa matriptase zymogen to the 120-kDa matriptaseHAI-1 complex (Fig. 2, Total MTP and Activated MTP, compare lanes 3 to lanes 1), suggesting that keratinocytes indeed
share this activation mechanism with other epithelial cells. In
addition to the 120-kDa matriptase-HAI-1 complex, the
85-kDa HAI-1 complex was also detected in these cells in
response to the mild acid exposure (Fig. 2, HAI-1, lane 3).
Acid-driven matriptase activation is thought to result from
an unusual feature of the matriptase zymogen. The intrinsic
activity of the zymogen form matriptase is greatly enhanced at a
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FIGURE 4. Acid exposure of HaCaT keratinocytes results in the activation
of prostasin associated with matriptase activation. HaCaT cells were incubated with basal media (Basal, lane 1) or phosphate buffer, pH 6.0, with 0.15 M
NaCl (PB⫹NaCl, lane 2) or phosphate buffer, pH 6.0 (PB, lane 3) for 30 min. Cell
lysates were extracted and subjected to immunoblot analyses for prostasin
using a prostasin polyclonal antibody. The lower panel (marked with an asterisk) containing proteins near the 35-kDa protein marker shows a longer exposure of the x-film to show the levels of latent prostasin.

Prostasin Activation Is Dependent on Matriptase—We next
set out to determine if the activation of prostasin in keratinocytes simply occurs at the same time as matriptase activation, or
if its activation is coupled to, and dependent on matriptase activation. As shown in Fig. 2, using the HAI-1 mAb, the formation
of the prostasin-HAI-1 complex can be induced by exposing
HaCaT cells to a pH 6.0 buffer, and NaCl can suppress complex
formation. Using a prostasin polyclonal antibody, we confirmed that the 85-kDa complex was not detected in HaCaT
keratinocytes before acid exposure (Fig. 4, lane 1). In response
to the acid exposure, the appearance of the 85-kDa complex can
be clearly detected by the prostasin polyclonal antibody (Fig. 4,
lane 3), and its appearance is suppressed by the inclusion of
NaCl in the pH 6.0 buffer (Fig. 4, lane 2), recapitulating the data
generated with the HAI-1 mAb shown in Fig. 2. Because HAI-1
only binds to active serine proteases, formation of the prostasin-HAI-1 complex should be at the cost of latent prostasin, in
a situation similar to the disappearance of 70-kDa latent
matriptase and the concomitant appearance of 120-kDa
matriptase-HAI-1 complex (Fig. 2). The prostasin polyclonal
OCTOBER 8, 2010 • VOLUME 285 • NUMBER 41

antibody used in the current study appears to be less sensitive to
latent prostasin than to prostasin-HAI-1 complex. Latent prostasin with a size close to the 35-kDa protein marker was clearly
detected in HaCaT cells only after exposing the nitrocellulose
membrane to x-ray film for a longer time (Fig. 4, lane 1 in low
panel). Nevertheless, the conversion of prostasin zymogen to
active prostasin and inactivation of active prostasin by the formation of the 85-kDa HAI-1 complex results in the levels of
latent prostasin being significantly decreased in parallel with
the formation of the 85-kDa complex (Fig. 4, low panel, compare lane 3 with lane 1). The reduction of zymogen activation
caused by the NaCl (Fig. 4, lane 2 in low panel) results in latent
prostasin being detected at intermediate levels (Fig. 4, lower
panel) consistent with the partial suppression of the appearance of the 85-kDa complex (Fig. 4, lower and upper panel).
These data clearly demonstrate that prostasin undergoes activation and HAI-1 complexation in keratinocytes in response to
acid exposure and that both matriptase and prostasin activation
are tightly coupled.
Matriptase has been shown to become active through an
autoactivation process (14), and prostasin activation does not
occur in the skin of matriptase-deficient mice (6). This suggests
that matriptase may serve as an upstream activator of prostasin.
To test this hypothesis we first generated three HaCaT clones
in which the level of matriptase expression had been suppressed
to various degrees by transduction with lentiviruses carrying
matriptase-targeting shRNAs, or non-targeting controls (Fig.
5A, Total MTP, 49, 52, 53, and NT). The levels of HAI-1 and
prostasin were not altered in these clones when compared with
the levels in the parental and non-target control cells (Fig. 5A,
HAI-1 and Prostasin). For better detection of prostasin, a commercially available prostasin monoclonal antibody was used,
which only detects the protease after heat-denaturation of the
sample prior to SDS-PAGE, which results in dissociation of the
prostasin-HAI-1 complex. When matriptase activation was
induced by acid exposure of the cells, formation of the 85-kDa
prostasin-HAI-1 complex along with 120-kDa matriptaseHAI-1 complex was clearly observed in the non-target control
clone (Fig. 5B, NT, compare lane 2 to lane 1), but was barely
detectible in the matriptase knockdown clones 49 and 52 (Fig.
5B, 49 and 52). These data clearly demonstrate that prostasin
activation depends on matriptase proteolytic action, providing
key evidence for a cascaded linkage between matriptase and
prostasin activation.
Matriptase and Prostasin Activation Kinetics in HaCaT Cells—
We further established the “lockstep” relationship between
matriptase activation and prostasin activation by comparing
their respective activation kinetics in response to acid exposure.
As rapidly as 3– 4 min after starting acid exposure, matriptase
began to become activated, with the active enzyme being immediately inhibited by binding to HAI-1 with the appearance of
the 120-kDa matriptase-HAI-1 complex detected by both
matriptase and HAI-1 mAbs (Fig. 6, Total MTP and HAI-1).
Matriptase activation reached a plateau after ⬃10 –15 min of
acid exposure as there was almost no latent matriptase left at
this point (Fig. 6, Total MTP). The appearance of the 85-kDa
prostasin-HAI-1 complex followed similar kinetics to the
appearance of the 120-kDa matriptase-HAI-1 complex demonJOURNAL OF BIOLOGICAL CHEMISTRY
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entiation, and the active enzymes generated are immediately
inhibited by binding to HAI-1. The constitutive activation of
the system followed by the immediate HAI-1-mediated inhibition of both matriptase and prostasin suggests that the proteolytic cascade not only plays an important role in epidermal differentiation but that its activity must also be under tight
control. Our data clearly demonstrate that matriptase is able to
act on its substrate even in the presence of overwhelming levels
of HAI-1. The rapid inhibition of active prostasin by HAI-1
further indicates that the tight regulation of the matriptaseprostasin cascade lies not only at the level of the initiator proDISCUSSION
tease matriptase but also at the secondary protease prostasin.
In the present study we investigate how a matriptase-initi- With such a tightly regulatory mechanism that only allows the
ated cell surface proteolytic cascade is regulated throughout the first two proteases of the cascade to have an extremely limited
course of epidermal differentiation. The proteolytic cascade is opportunity to act on their downstream substrates, it is reasonconstitutively activated from an early stage of epidermal differ- able to suppose that deregulation of the cascade at either one of
the two proteases or at their cognate
inhibitor HAI-1 would affect the
entire protease cascade, and in turn
derail epidermal differentiation.
Although several protein substrates have been identified for
matriptase based on the cleavage
preferences of the enzyme, prostasin is the first matriptase substrate
for whose activation can be demonstrated during the course of matriptase’s own activation and in the
context of rapid HAI-1-mediated
inhibition of active matriptase.
The functional linkage between
matriptase and prostasin activation
is consistent with the observation
FIGURE 5. Prostasin activation is dependent on matriptase. A, generation of matriptase knockdown HaCaT that prostasin activation does not
cells. HaCaT cells were infected with lentiviruses bearing three different matriptase-targeting shRNAs and a
non-targeting shRNA. Stable clones were selected with puromycin, and cell lysates were analyzed by immu- occur in the skin of matriptase-definoblot for total matriptase (Total MTP), HAI-1, and prostasin. Total matriptase and HAI-1 were detected under cient mice (6). The very similar epinon-reducing and non-boiled conditions. Prostasin was detected under reduced and boiled conditions using
a prostasin monoclonal antibody. B, prostasin activation is dependent on matriptase. The matriptase knock- dermal defects that are observed in
down clones (49 and 52) and the non-target control (NT) cells were either exposed to basal medium (Basal) or matriptase-deficient and prostasinphosphate buffer, pH 6.0 (PB), for 30 min to induce activation of matriptase and prostasin. Formation of the deficient mice strongly suggest that
prostasin-HAI-1 complex, as an indication of prostasin activation, was analyzed by immunoblot using HAI-1
prostasin may be the predominant
mAb M19.

strated using the HAI-1 mAb M19 (Fig. 6, HAI-1). The kinetics
of prostasin-HAI-1 complex formation can also be followed
using the prostasin polyclonal antibody (Fig. 6, Prostasin).
These kinetics studies demonstrate that matriptase activation,
prostasin activation, and inhibition of both proteases by HAI-1
occur at almost the same time in human keratinocytes. These
data provide evidence that, despite the extremely tight control
by HAI-1 and the short period in which free active matriptase
is present, it is able to activate its downstream substrate,
prostasin.

FIGURE 6. Activation and HAI-1 binding kinetics of the matriptase-prostasin proteolytic cascade. HaCaT cells were treated with either basal medium (C)
or phosphate buffer, pH 6.0, and harvested at indicated time points (minutes). Cell lysates were prepared by lysis with 1% Triton X-100 in PBS and followed by
immunoblot analyses for total matriptase (Total MTP), HAI-1, and prostasin.
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FIGURE 7. The model for the regulation of matriptase-prostasin proteolytic cascade. A schematic model of the activation and inactivation of matriptase
and prostasin is presented. Both matriptase and prostasin are synthesized as single chain zymogens and anchored on cell membrane. Matriptase undergoes
autoactivation via the interaction of two zymogen molecules to generate active matriptase. Active matriptase subsequently activate prostasin and the
downstream substrates. Both active matriptase and active prostasin are short-lived due to the rapid HAI-1-mediated inhibition.

substrate of matriptase in this tissue functional context, and
that the lack of prostasin activation may be responsible for the
majority of the defects associated with matriptase deletion.
Despite their close relationship in skin biology, matriptase and
prostasin may not function in tandem in other epithelial cells,
or at least their functional linkage in other epithelial cells is not
as straightforward as in keratinocytes. During the development
and progression of squamous cells carcinoma induced by initiation with 7,12-dimethylbenzanthracene and promotion with
phorbol 12-myristate 13-acetate, matriptase and prostasin are
eventually expressed in separate parts of the tumors (26). In
polarized epithelial cells grown in moist environments,
matriptase is targeted to basolateral plasma membrane and
prostasin, a glycosylphosphatidylinositol-anchored protein, is
likely targeted to the apical plasma membrane (27). Although a
glycosylphosphatidylinositol-anchored protein might be targeted to the apical surface after transiently moving to the basolateral plasma membrane, it is conceivable that the different
subcellular localizations of matriptase and prostasin in polarized epithelial cells renders the ability of matriptase to activate
prostatin less relevant. Different mechanisms are likely
employed by other epithelial cells to activate prostasin, if
matriptase is not the activator. Furthermore, the rapid inhibition of prostasin by HAI-1 also may not be a universal mechanism. Prostasin was initially isolated from the seminal fluid
as an active protease, but not in an HAI-1 complex (28). The
epidermis is a specialized epithelium designed to encounter
the terrestrial environment, and although keratinocytes
resemble other epithelial types, keratinocytes undergo progressive remodeling of cell morphology and tissue structure
during epidermal differentiation. These cellular remodeling
events may alter the subcellular distribution of matriptase
and prostasin and allow matriptase and prostasin to team up
to form a relatively keratinocyte-selective cell surface protease cascade.
OCTOBER 8, 2010 • VOLUME 285 • NUMBER 41

The epithelial sodium channel (ENaC), a membrane-bound
ion channel, is located in the apical membrane of polarized
epithelial cells (29). Both prostasin and matriptase have been
demonstrated to activate ENaC, resulting in their alternative
names as mouse channel activating proteases 1 and 2 (mCAP 1
and mCAP 3, respectively) (30). Because matriptase is targeted
to the basolateral membrane in polarized epithelial cells where
it is activated and immediately inhibited by HAI-1 binding (31),
it is of interest to determine whether or how matriptase could
activate the apically localized ENaC. In contrast to matriptase,
prostasin is co-localized with ENaC at the apical plasma membrane, and this co-localization makes prostasin a more likely
candidate protease activator for ENaC in polarized epithelial
cells. In contrast to some non-keratinocyte epithelial cells in
which the inhibition of prostasin by HAI-1 seems less effective,
active prostasin in keratinocytes much like active matriptase is
a short-lived species. It remains to be determined whether
prostasin is still an effective activator of ENaC in keratinocytes
(32).
In conclusion, the matriptase-prostasin proteolytic cascade,
a relatively keratinocyte-selective, and tightly regulated cell
surface proteolysis system, is essential for epidermal differentiation. Both matriptase and prostasin zymogens and their cognate inhibitor HAI-1 are likely co-localized and anchored at the
cell membrane. In response to activation stimuli, such as acid
exposure or signals of epidermal tissue differentiation, the
matriptase zymogen undergoes autoactivation mediated via the
formation a homodimer that generates active matriptase that in
turn rapidly activates prostasin. Both active matriptase and
active prostasin likely also rapidly activate downstream substrates before HAI-1 moves in and inhibits both proteases and
suppresses the activity of the proteolytic cascade. Although
HAI-1 contains two Kunitz domains, Kunitz domain 1 at the N
terminus is likely responsible for the inhibition (33). We summarize these molecular events associated with activation and
JOURNAL OF BIOLOGICAL CHEMISTRY
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inactivation of the protease cascade in Fig. 7. The unprecedentedly tight control of this cell surface proteolytic cascade allows
keratinocytes to undergo differentiation through a precisely
programmed mechanism.
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